Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Ross Andrew L., Director. Director active across 1 company, notably iSpecimen Inc.. Aggregated, 5 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €1k. Activity tracked since 17 June 2021. The latest transaction was filed on 17 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Andrew L. Ross is a Director of iSpecimen Inc. In this role, he participates in the governance of the company and strategic decision-making. iSpecimen Inc. specializes in the collection and distribution of biological samples. Andrew brings valuable expertise in leadership and strategy.